BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 21787400)

  • 1. Rare variants in the ATM gene and risk of breast cancer.
    Goldgar DE; Healey S; Dowty JG; Da Silva L; Chen X; Spurdle AB; Terry MB; Daly MJ; Buys SM; Southey MC; Andrulis I; John EM; ; ; Khanna KK; Hopper JL; Oefner PJ; Lakhani S; Chenevix-Trench G
    Breast Cancer Res; 2011 Jul; 13(4):R73. PubMed ID: 21787400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
    Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
    Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
    Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
    Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
    Tavtigian SV; Oefner PJ; Babikyan D; Hartmann A; Healey S; Le Calvez-Kelm F; Lesueur F; Byrnes GB; Chuang SC; Forey N; Feuchtinger C; Gioia L; Hall J; Hashibe M; Herte B; McKay-Chopin S; Thomas A; Vallée MP; Voegele C; Webb PM; Whiteman DC; ; ; ; Sangrajrang S; Hopper JL; Southey MC; Andrulis IL; John EM; Chenevix-Trench G
    Am J Hum Genet; 2009 Oct; 85(4):427-46. PubMed ID: 19781682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
    Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
    Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
    J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
    Hirsch AE; Atencio DP; Rosenstein BS
    Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
    Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
    Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
    Concannon P; Haile RW; Børresen-Dale AL; Rosenstein BS; Gatti RA; Teraoka SN; Diep TA; Jansen L; Atencio DP; Langholz B; Capanu M; Liang X; Begg CB; Thomas DC; Bernstein L; Olsen JH; Malone KE; Lynch CF; Anton-Culver H; Bernstein JL;
    Cancer Res; 2008 Aug; 68(16):6486-91. PubMed ID: 18701470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
    Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
    J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.
    Mitui M; Nahas SA; Du LT; Yang Z; Lai CH; Nakamura K; Arroyo S; Scott S; Purayidom A; Concannon P; Lavin M; Gatti RA
    Hum Mutat; 2009 Jan; 30(1):12-21. PubMed ID: 18634022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
    Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
    Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.
    Fletcher O; Johnson N; dos Santos Silva I; Orr N; Ashworth A; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Waltes R; Bremer M; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Humphreys K; Liu J; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; ; ; Beesley J; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Ko YD; Hamann U; ; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Milne RL; Benítez J; Arias JI; Pita G; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Broeks A; Schmidt MK; van Leeuwen FE; Van't Veer LJ; Margolin S; Lindblom A; Humphreys MK; Morrison J; Platte R; Easton DF; Peto J;
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2143-51. PubMed ID: 20826828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.
    Bretsky P; Haiman CA; Gilad S; Yahalom J; Grossman A; Paglin S; Van Den Berg D; Kolonel LN; Skaliter R; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):733-8. PubMed ID: 12917204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of common ATM variants with familial breast cancer in a South American population.
    González-Hormazábal P; Bravo T; Blanco R; Valenzuela CY; Gómez F; Waugh E; Peralta O; Ortuzar W; Reyes JM; Jara L
    BMC Cancer; 2008 Apr; 8():117. PubMed ID: 18433505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.